< Back to Article

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study

Table 6

Risk prediction models for CKD progression in 999 participants and all-cause mortality in 1,732 participants using different estimating equations for eGFR.

Table 6